Skip to main content

From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Weekly Wrap 27 June

Bell Direct
June 27, 2025

Morning Bell 26 June

Bell Direct
June 26, 2025

Morning Bell 25 June

Bell Direct
June 25, 2025

Morning Bell 24 June

Bell Direct
June 24, 2025

Morning Bell 23 June

Bell Direct
June 23, 2025

Weekly Wrap 20 June

Bell Direct
June 20, 2025

Morning Bell 19 June

Bell Direct
June 19, 2025

Morning Bell 18 June

Grady Wulff
June 18, 2025

Morning Bell 17 June

Sophia Mavridis
June 17, 2025

Morning Bell 16 June

Bell Direct
June 16, 2025

Weekly Wrap 13 June

Bell Direct
June 13, 2025